VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates

Li Chen, Javier Montserat, David S. Lawrence, Zhong-Yin Zhang

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The dual-specificity protein phosphatases have recently been shown to act as key regulators of mitogenic signaling pathways as well as of the cell cycle process. The are unusual catalysts in that they can utilize protein substrates containing phosphotyrosine as well as phosphoserine/threonine. The dual-specificity phosphatases and the protein tyrosine phosphatases (PTPase) share the active site motif (H/V)C(X)5R(S/T) but display little amino acid sequence identity outside of the active site. Although the dual-specificity phosphatases and the PTPases appear to bring about phosphate monoester hydrolysis through a similar mechanism, there is very limited information about the structural features that control the substrate specificity for the two groups of enzymes. As a first step in the development of selective dual- specificity phosphatase inhibitors, we have examined the active site substrate specificity of the human dual-specificity phosphatase, VHR [for VH1-Related; Ishibashi et al. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 12170- 12174]. Like the tyrosine-specific PTP1, VHR also preferentially catalyzes the hydrolysis of aromatic phosphates. However, we demonstrate herein that relatively modest changes in the substitution patterns on the phosphorylated aromatic nucleus generates dramatic, and differential, swings in substrate selectivity for VHR and PTP1. For example, VHR appears to be significantly more accommodating than PTP1 toward sterically-demanding substrates. Thus, the active site specificity of these two protein phosphatases is decidedly dissimilar. In addition, we have also identified several low molecular weight compounds that are more efficient substrates than the most potent peptidic substrates ever reported for VHR. Finally, we have shown that the Michaelis constants exhibited by these substrates are accurate assessments of enzyme affinity. Consequently, it should be possible to develop phosphatase- selective inhibitors based upon the distinct substrate specificities of these enzymes.

Original languageEnglish (US)
Pages (from-to)9349-9354
Number of pages6
JournalBiochemistry
Volume35
Issue number29
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Dual-Specificity Phosphatases
Phosphoprotein Phosphatases
Catalytic Domain
Molecular Weight
Molecular weight
Substrate Specificity
Substrates
Hydrolysis
Enzymes
Phosphates
Phosphoserine
Phosphotyrosine
Protein Tyrosine Phosphatases
Threonine
Phosphoric Monoester Hydrolases
Tyrosine
Amino Acid Sequence
Cell Cycle
Substitution reactions
Cells

ASJC Scopus subject areas

  • Biochemistry

Cite this

VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates. / Chen, Li; Montserat, Javier; Lawrence, David S.; Zhang, Zhong-Yin.

In: Biochemistry, Vol. 35, No. 29, 1996, p. 9349-9354.

Research output: Contribution to journalArticle

@article{adf8b1f5b0724b0e97c9cf5b7bce8637,
title = "VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates",
abstract = "The dual-specificity protein phosphatases have recently been shown to act as key regulators of mitogenic signaling pathways as well as of the cell cycle process. The are unusual catalysts in that they can utilize protein substrates containing phosphotyrosine as well as phosphoserine/threonine. The dual-specificity phosphatases and the protein tyrosine phosphatases (PTPase) share the active site motif (H/V)C(X)5R(S/T) but display little amino acid sequence identity outside of the active site. Although the dual-specificity phosphatases and the PTPases appear to bring about phosphate monoester hydrolysis through a similar mechanism, there is very limited information about the structural features that control the substrate specificity for the two groups of enzymes. As a first step in the development of selective dual- specificity phosphatase inhibitors, we have examined the active site substrate specificity of the human dual-specificity phosphatase, VHR [for VH1-Related; Ishibashi et al. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 12170- 12174]. Like the tyrosine-specific PTP1, VHR also preferentially catalyzes the hydrolysis of aromatic phosphates. However, we demonstrate herein that relatively modest changes in the substitution patterns on the phosphorylated aromatic nucleus generates dramatic, and differential, swings in substrate selectivity for VHR and PTP1. For example, VHR appears to be significantly more accommodating than PTP1 toward sterically-demanding substrates. Thus, the active site specificity of these two protein phosphatases is decidedly dissimilar. In addition, we have also identified several low molecular weight compounds that are more efficient substrates than the most potent peptidic substrates ever reported for VHR. Finally, we have shown that the Michaelis constants exhibited by these substrates are accurate assessments of enzyme affinity. Consequently, it should be possible to develop phosphatase- selective inhibitors based upon the distinct substrate specificities of these enzymes.",
author = "Li Chen and Javier Montserat and Lawrence, {David S.} and Zhong-Yin Zhang",
year = "1996",
doi = "10.1021/bi960700+",
language = "English (US)",
volume = "35",
pages = "9349--9354",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "29",

}

TY - JOUR

T1 - VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates

AU - Chen, Li

AU - Montserat, Javier

AU - Lawrence, David S.

AU - Zhang, Zhong-Yin

PY - 1996

Y1 - 1996

N2 - The dual-specificity protein phosphatases have recently been shown to act as key regulators of mitogenic signaling pathways as well as of the cell cycle process. The are unusual catalysts in that they can utilize protein substrates containing phosphotyrosine as well as phosphoserine/threonine. The dual-specificity phosphatases and the protein tyrosine phosphatases (PTPase) share the active site motif (H/V)C(X)5R(S/T) but display little amino acid sequence identity outside of the active site. Although the dual-specificity phosphatases and the PTPases appear to bring about phosphate monoester hydrolysis through a similar mechanism, there is very limited information about the structural features that control the substrate specificity for the two groups of enzymes. As a first step in the development of selective dual- specificity phosphatase inhibitors, we have examined the active site substrate specificity of the human dual-specificity phosphatase, VHR [for VH1-Related; Ishibashi et al. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 12170- 12174]. Like the tyrosine-specific PTP1, VHR also preferentially catalyzes the hydrolysis of aromatic phosphates. However, we demonstrate herein that relatively modest changes in the substitution patterns on the phosphorylated aromatic nucleus generates dramatic, and differential, swings in substrate selectivity for VHR and PTP1. For example, VHR appears to be significantly more accommodating than PTP1 toward sterically-demanding substrates. Thus, the active site specificity of these two protein phosphatases is decidedly dissimilar. In addition, we have also identified several low molecular weight compounds that are more efficient substrates than the most potent peptidic substrates ever reported for VHR. Finally, we have shown that the Michaelis constants exhibited by these substrates are accurate assessments of enzyme affinity. Consequently, it should be possible to develop phosphatase- selective inhibitors based upon the distinct substrate specificities of these enzymes.

AB - The dual-specificity protein phosphatases have recently been shown to act as key regulators of mitogenic signaling pathways as well as of the cell cycle process. The are unusual catalysts in that they can utilize protein substrates containing phosphotyrosine as well as phosphoserine/threonine. The dual-specificity phosphatases and the protein tyrosine phosphatases (PTPase) share the active site motif (H/V)C(X)5R(S/T) but display little amino acid sequence identity outside of the active site. Although the dual-specificity phosphatases and the PTPases appear to bring about phosphate monoester hydrolysis through a similar mechanism, there is very limited information about the structural features that control the substrate specificity for the two groups of enzymes. As a first step in the development of selective dual- specificity phosphatase inhibitors, we have examined the active site substrate specificity of the human dual-specificity phosphatase, VHR [for VH1-Related; Ishibashi et al. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 12170- 12174]. Like the tyrosine-specific PTP1, VHR also preferentially catalyzes the hydrolysis of aromatic phosphates. However, we demonstrate herein that relatively modest changes in the substitution patterns on the phosphorylated aromatic nucleus generates dramatic, and differential, swings in substrate selectivity for VHR and PTP1. For example, VHR appears to be significantly more accommodating than PTP1 toward sterically-demanding substrates. Thus, the active site specificity of these two protein phosphatases is decidedly dissimilar. In addition, we have also identified several low molecular weight compounds that are more efficient substrates than the most potent peptidic substrates ever reported for VHR. Finally, we have shown that the Michaelis constants exhibited by these substrates are accurate assessments of enzyme affinity. Consequently, it should be possible to develop phosphatase- selective inhibitors based upon the distinct substrate specificities of these enzymes.

UR - http://www.scopus.com/inward/record.url?scp=0029739468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029739468&partnerID=8YFLogxK

U2 - 10.1021/bi960700+

DO - 10.1021/bi960700+

M3 - Article

VL - 35

SP - 9349

EP - 9354

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 29

ER -